Clinical trial
HD12 for Advanced Stages
NCT00265031 · University of Cologne, Other · Completed
Key facts
| NCT number | NCT00265031 |
|---|---|
| Title | HD12 for Advanced Stages |
| Lead sponsor | University of Cologne, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hodgkin´s Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | Cyclophosphamide, Adriamycin, Etoposide, Procarbazine, Prednisone, Vincristine, Bleomycin, radiation therapy |
| Start date | Jan 1, 1999 |
| First posted | Dec 13, 2005 |
| Last update posted | Jun 25, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: